Device / Technology News

RSS

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.

27 Jul 2011

Stenting prevents recurrence of aneurysms after minimally invasive 'coiling' procedure

The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure, according to new research by Johns Hopkins physicians.

27 Jul 2011

Gates Foundation awards phase 1 grant to St. Joseph's scientist for post-partum research

The Bill and Melinda Gates Foundation has awarded Robert Garfield, PhD, a researcher at St. Joseph's Hospital and Medical Center in Phoenix, a $100,000 phase 1 grant to develop a device to prevent post-partum hemorrhage.

27 Jul 2011

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial.

27 Jul 2011

FDA clears ArthroCare's SpeedFix Suture System

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix Suture System.

27 Jul 2011

FUJIFILM announces commercial availability of Synapse version 6.0

FUJIFILM Medical Systems U.S.A. today announced the commercial availability of version 6.0, the latest version of the company's Synapse RIS and Synapse TeleRIS applications.

26 Jul 2011

Kadmon, Dyax enter license agreement for antibody phage display libraries

Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary "gold-standard" antibody phage display libraries for the discovery and development of therapeutic antibodies.

26 Jul 2011

Superdrug, Orabrush to market tongue cleaner in 500 locations across the UK

Orabrush today announced that Superdrug will begin carrying the Orabrush tongue cleaner in 500 locations across the United Kingdom. Recently awarded UK's Best For Personal Care by Verdict Research, Superdrug is the UK's second-largest beauty and health retailer.

26 Jul 2011

THERAPY trial to evaluate benefits of catheter-based intervention for acute ischemic stroke

During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.

26 Jul 2011

BioWa, arGEN-X sign license agreement for POTELLIGENT Technology

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.

26 Jul 2011

Rwanda testing non-surgical circumcision device in national campaign

BBC News on Sunday looked at Rwanda's national circumcision campaign, which began in December 2010 to help lower the incidence of HIV in the country.

26 Jul 2011

CANARY software can protect nation's water systems from contamination

Americans are used to drinking from the kitchen tap without fear of harm, even though water utilities might be vulnerable to terrorist attacks or natural contaminants.

26 Jul 2011

New larger lumen catheter for clot removal in ischemic stroke patients

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC 070 Catheter.

26 Jul 2011

Artificial lung reaches efficiencies akin to the genuine organ

An artificial lung built by Cleveland researchers has reached efficiencies akin to the genuine organ, using air - not pure oxygen as current man-made lungs require - for the source of the essential element.

26 Jul 2011

GCMS, PBS Biotech sign distribution agreement for single-use bioreactors in Korea

PBS Biotech, Inc., a developer of state of the art single-use bioreactors for the fast growing biotechnology market, announced today it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp. (GCMS), a division of Green Cross Corporation, one of Korea's largest pharmaceutical firms.

26 Jul 2011

Daiichi Sankyo to deploy Veeva CRM for strengthening customer engagements in the UK

Veeva Systems announced today that Daiichi Sankyo, one of the world's top 20 pharmaceutical companies, is replacing its legacy, on-premise Customer Relationship Management (CRM) system with Veeva CRM in the UK.

26 Jul 2011

Tumor marker, endoscopic ultrasound more likely to detect stage 1 pancreatic cancer

Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.

26 Jul 2011

fMRI scans can identify biological signs of autism in toddlers

The biological causes of autism are still not understood. A diagnosis of autism is only possible after ages three or four and the tests are subjective, based on behavioral symptoms. Now, in research that appeared in Neuron, scientists at the Weizmann Institute of Science, Carnegie Mellon University, and the University of California, San Diego have found, for the first time, a method that can accurately identify a biological sign of autism in very young toddlers.

26 Jul 2011

CHroniCles site aims to document important stories of health centers

The RCHN Community Health Foundation and the Geiger Gibson Program in Community Health Policy at the George Washington University School of Public Health and Health Services today announced the launch of CHroniCles, a dynamic, multi-media website dedicated to the living history of the community health center movement.

26 Jul 2011

Resolute drug-eluting stent superior to Taxus DES for coronary artery disease

The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.

26 Jul 2011